Device Trial Radar · NCT03232437
Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System
Last checked: Nov 20, 2026Latest source record: Jul 28, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6
Actual
Start
Jun 14, 2017
Primary completion
Jun 21, 2017
Study completion Jun 21, 2017
Sponsor
- Lead sponsor
- Jana CareNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- The Forsyth Institute; Orange County Research Center; ActivMed Practices & Research
- First posted
- Jul 28, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A three site study to evaluate the reproducibility of the Aina HbA1c Monitoring System in quantitative determination of glycosylated hemoglobin (HbA1c) took place at the following sites: 1. Forsyth Institute in Cambridge, MA 2. Orange County Research Center in Tustin, CA 3. ActivMed Practices \& Research in Methuen, MA
Conditions
- Diabetes
Interventions
Aina HbA1c Monitoring SystemDevice
Monitoring test for quantitative determination of HbA1c
Primary outcomes
What the sponsor says the trial is designed to measure.
- Precision (as measured by %CV) of HbA1c measurementsTime frame: Each sample was measured in triplicate, twice per day, over the course of five days
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Orange County Research Center
Tustin, California
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.